|
|
Alpha Teknova Inc (NASDAQ: TKNO) |
|
Price: $6.9100
$-0.05 
-0.647%
|
| Day's High:
| $6.929999828338623
| Week Perf:
| -4.56 %
|
| Day's Low: |
$ 6.71 |
30 Day Perf: |
-1.85 % |
| Volume (M): |
88,118 |
52 Wk High: |
$ 7.84 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$4.43 |
| Open: |
$6.86 |
52 Wk Low: |
$1.91 |
|
|
| Market Capitalization (Millions $) |
371 |
| Shares
Outstanding (Millions) |
54 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
43 |
| Net Income (TTM) (Millions $) |
-17 |
| Cash Flow (TTM) (Millions $) |
1 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Alpha Teknova Inc is a technology company specializing in product development and innovation. The company focuses on providing cutting-edge solutions for various industries including biotechnology, pharmaceuticals, and research. Alpha Teknova Inc aims to deliver high-quality products, such as reagents, enzymes, and assays, that meet the needs of its clients and contribute to advancements in science and medicine. The company is known for its commitment to innovation, quality, and customer satisfaction.
Company Address: 2451 Bert Dr. Hollister 95023 CA
Company Phone Number: 637-1100 Stock Exchange / Ticker: NASDAQ TKNO
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Stocks on the Move
Published Thu, Aug 15 2024 11:17 AM UTC
Investing in the stock market can be both captivating and alluring, often seen as a pathway to rapid wealth accumulation. With nearly endless opportunities for financial growth, many investors are driven by the potential of high returns. Yet, as the market fluctuates, potential investors must navigate through both promising and perilous stock choices.Currently, one of the mo...
|
| Shares
Published Fri, Jul 12 2024 8:26 PM UTC
Additionally, Teknova has also completed a registered direct offering, where it issued and sold up to 1,086,485 shares of common stock at $1.85 per share. In a concurrent private placement, the company sold an additional 11,299,993 shares at the same purchase price. These offerings were priced based on the consolidated closing bid price under Nasdaq rules.
In total,...
|
| Management Announcement
Published Fri, Jul 12 2024 5:00 AM UTC
HOLLISTER, Calif., July 11, 2024 - Alpha Teknova, Inc. (Teknova), a renowned producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, has recently disclosed a significant development in its financial strategy. The company announced that it has entered into a definitive agreement for...
|
| Product Service News
Published Tue, May 7 2024 2:01 PM UTC
Teknova Launches Proprietary Build-Tek Solutions Custom Configurator and Latest AAV-Tek Product to Further Accelerate Novel Therapy DevelopmentInnovative biotechnology company Teknova has announced the launch of its groundbreaking Build-Tek Solutions Custom Configurator and the latest product in its AAV-Tek range. These tools are set to revolutionize the field of novel thera...
|
| Shares
Published Mon, Sep 18 2023 12:00 PM UTC
Teknova Announces $22.9 Million Offering to Accelerate Research and Development of Life-saving Therapies
HOLLISTER, Calif., Sept. 18, 2023 - Alpha Teknova, Inc. (Teknova) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, revealed today its plans to raise up...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
-0.31 $ |
| Revenues (TTM) |
0.81 $
|
| Cash Flow (TTM) |
0.02 $ |
| Cash |
0.33 $
|
| Book Value |
1.17 $
|
| Dividend (TTM) |
0 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
- |
| Net
Income per Employee (TTM) |
- |
| Receivable Turnover Ratio (TTM) |
8.33 |
| Inventory Turnover Ratio (TTM) |
4.08 |
| Asset Turnover Ratio (TTM) |
0.43 |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.31 $
|
| Revenues (TTM) |
0.81 $ |
| Cash Flow (TTM) |
0.02 $ |
| Cash |
0.33 $
|
| Book Value |
1.17 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| Lab Essentials |
|
 144.27 % |
of total Revenue |
| Clinical Solutions |
|
37.53 % |
of total Revenue |
| Other |
|
8.55 % |
of total Revenue |
| US |
|
182.36 % |
of total Revenue |
| |
On March 4 2025 the Alpha Teknova Inc provided following guidance
nnAlpha Teknova Inc. Financial Outlook and Performance Summarynn
On March 4, 2025, Alpha Teknova Inc. released its financial results for the fourth quarter and the full year of 2024. The company highlighted a solid performance, reporting total revenue for the full year at $37.7 million. This figure reflects a 3% increase compared to the previous year, aligning with the company’s initial revenue guidance.
In the fourth quarter of 2024, Alpha Teknova generated total revenue of $9.3 million, representing an impressive 18% growth over the same quarter from the prior year. This positive trend underscores the company’s consistent demand and effective market strategies.
Looking ahead,...
|
|
|
